Canaccord lowered the firm’s price target on Ameresco to $36 from $50 and keeps a Buy rating on the shares. The firm said the quarter was healthy and even though 2024 EBITDA guidance was a little disappointing, the underlying trends look good; backlog grew again to record levels.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AMRC: